Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2026-01-04 @ 4:57 AM
Study NCT ID:
NCT05999604
Status:
RECRUITING
Last Update Posted:
2025-09-29
First Post:
2023-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial
Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-11
First Submit QC Date:
None
Study First Post Date:
2023-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-26
Last Update Post Date:
2025-09-29
Last Update Post Date Type:
ESTIMATED